GENOMIKI

Delhi, India Founded: 2020 • Age: 6 yrs
Genome-informatics analysis is provided for research and clinical needs.

About GENOMIKI

GENOMIKI is a Healthcare company based in Delhi (India) founded in 2020 by Deeksha Bhartiya. Genome-informatics analysis is provided for research and clinical needs. GENOMIKI has raised $72.18 thousand across 1 funding round. Its Indian entity Genomiki Solutions Private Limited reported revenue of β‚Ή38.3 Lakh. GENOMIKI offers products and services including Onquer, InheriGene, and Customized Solutions. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.

Company details

Founded in 2020 and based in Delhi, India, genome-informatics services are offered by GENOMIKI in the biotechnology sector. High-throughput next-generation sequencing datasets are analyzed to produce reliable and reproducible outcomes. Emphasis is placed on data management and privacy protocols. Solutions are tailored for both research applications and clinical requirements, supporting various genomic workflows.

  • Headquarters Delhi, India
  • Founders Deeksha Bhartiya
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website genomiki.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Genomiki Solutions Private Limited
  • Date of Incorporation 29 Sep, 2021
  • Jurisdiction Noida, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹38.3 Lakh

    FY 2025 · +92% YoY

  • Net Loss
    -₹7.4 Lakh

    FY 2025 · -19% margin

  • EBITDA
    -₹7.4 Lakh

    FY 2025 · -19% margin

  • Total Equity Funding
    $72.18K (USD)

    in 1 rounds

  • Latest Funding Round
    $72.18K (USD), Seed

    Feb 2024

Products & Services of GENOMIKI

GENOMIKI offers a comprehensive portfolio of products and services, including Onquer, InheriGene, and Customized Solutions.

Onquer
Diagnostic Platform

Platform for identifying genetic causes in rare disorders

InheriGene
Genetics Analysis

Service for analyzing inherited genes in medical research

Customized Solutions
Bioinformatics Services

Tailored analysis for unique research and clinical needs

Funding Insights of GENOMIKI

GENOMIKI has successfully raised a total of $72.18K through 1 strategic funding round. The most recent funding activity was a Seed round of $72.18 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $72,177
  • Total Rounds 1
  • Last Round Seed β€” $72,177
  • First Round $72,177

    (Feb 2024)

All 1 funding rounds of GENOMIKI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024$72,177Seed––
–

Board of directors of Genomiki Solutions Private Limited (GENOMIKI)

Genomiki Solutions Private Limited is the primary company behind GENOMIKI. The board of Genomiki Solutions Private Limited currently have 2 directors; the longest-serving is Deeksha Bhartiya, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Deeksha Bhartiya
DIN 09338959
Director29 Sep 20215 yrsGenomiki Solutions Private Limited
Meena Bhartiya
DIN 09338960
Director29 Sep 20215 yrsGenomiki Solutions Private Limited

People of GENOMIKI

1 people are tracked at GENOMIKI (1 in leadership).

NameRoleGroup
FounderLeadership
Premium access

Complete people profiles for GENOMIKI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of GENOMIKI

Figures of Genomiki Solutions Private Limited, the primary company behind GENOMIKI, for FY 2025. Revenue was ₹38.3 Lakh (+92% year on year). Net loss was -₹7.4 Lakh (-19% margin). EBITDA was -₹7.4 Lakh (-19% margin). Revenue has grown at a compounded annual rate of +172% over three years.

  • ₹38.3 LakhRevenue · FY 2025 · +92% YoY
  • -₹7.4 LakhNet loss · -19% margin
  • -₹7.4 LakhEBITDA · -19% margin
  • ₹1 LakhPaid-up capital
  • +172%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Genomiki Solutions Private Limited are on its company page.

Premium access

Detailed financial statements for GENOMIKI

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of GENOMIKI

2 dated milestones of GENOMIKI across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded GENOMIKI is founded.
  2. Funding First funding round of $72K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about GENOMIKI

GENOMIKI was founded in 2020 and raised its 1st funding round 4 years after it was founded.

GENOMIKI is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

GENOMIKI is a funded company, having raised a total of $72.18K across 1 funding round to date. The company's 1st funding round was a Seed of $72.18K, raised on Feb 2024.

The primary company behind GENOMIKI, Genomiki Solutions Private Limited, reported revenue of β‚Ή38.3 Lakh for FY 2025, up 92% year on year.

Founded in 2020 and based in Delhi, India, genome-informatics services are offered by GENOMIKI in the biotechnology sector. High-throughput next-generation sequencing datasets are analyzed to produce reliable and reproducible outcomes. Emphasis is placed on data management and privacy protocols. Solutions are tailored for both research applications and clinical requirements, supporting various genomic workflows.

GENOMIKI offers Onquer, InheriGene, and Customized Solutions.

GENOMIKI operates through Genomiki Solutions Private Limited.

The legal entities of GENOMIKI currently have 2 directors, including Deeksha Bhartiya, Meena Bhartiya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available